Recently, in eight children affected by FCD type II, the inflammatory molecule signaling of high-mobility group box 1 (HMGB1) through Toll-like receptor 4 (HMGB1-TLR4), was found to be altered. This evidence concerns the gene TLR4 and isolated focal cortical dysplasia type II.